SEARCH RESULTS FOR: (*Imitation Laguna College of Art*)(71337 results)

Export results
Only the first 10,000 results were returned. Filter these results or refine your query. Some pre-built queries with more than 10,000 results are available for download.
Company Name Brand Name GMDN Term Name GMDN Term Status FDA Product Code Name FDA Product Code Device Packaged As Sterile Sterilization Prior To Use Issuing Agency Device Size Device Size Type Device Class Implantable

Show Filters

Scrotal Bioflex® Cylinder Set with Pump - Narrow
Coloplast A/S
90-9916SNC
In Commercial Distribution

  • 05708932323604 ()

  • Length: 16 Centimeter
90-9916SNC

  • Inflatable penile prosthesis
Infrapubic Bioflex® Cylinder Set with Pump - Narrow
Coloplast A/S
90-9818INC
In Commercial Distribution

  • 05708932322584 ()

  • Length: 18 Centimeter
90-9818INC

  • Inflatable penile prosthesis
Infrapubic Bioflex® Cylinder Set with Pump - Narrow
Coloplast A/S
90-9816INC
In Commercial Distribution

  • 05708932322348 ()

  • Length: 16 Centimeter
90-9816INC

  • Inflatable penile prosthesis
Titan OTR Pump
Coloplast A/S
90-9000KCOTR
In Commercial Distribution

  • 05708932319744 ()
90-9000KCOTR

  • Inflatable penile prosthesis
Pump
Coloplast A/S
90-9000KC
In Commercial Distribution

  • 05708932319621 ()
90-9000KC

  • Inflatable penile prosthesis
The TherOx DownStream System, is indicated for the preparation and delivery of SuperSaturated Oxygen Therapy (SSO2 Therapy) to targeted ischemic regions perfused by the patient’s left anterior descending coronary artery immediately following revascularization by means of percutaneous coronary intervention (PCI) with stenting that has been completed within 6 hours after the onset of anterior acute myocardial infarction (AMI) symptoms caused by a left anterior descending artery infarct lesion.
THEROX, INC.
SSO2 - 5.0
In Commercial Distribution

  • 20862478000463 ()
  • 00862478000469 ()
  • 10862478000466 ()

  • 5F


  • Supersaturated oxygen therapy system catheter
The TherOx DownStream System, is indicated for the preparation and delivery of SuperSaturated Oxygen Therapy (SSO2 Therapy) to targeted ischemic regions perfused by the patient’s left anterior descending coronary artery immediately following revascularization by means of percutaneous coronary intervention (PCI) with stenting that has been completed within 6 hours after the onset of anterior acute myocardial infarction (AMI) symptoms caused by a left anterior descending artery infarct lesion.
THEROX, INC.
SSO2 - 4.5
In Commercial Distribution

  • 20862478000456 ()
  • 00862478000452 ()
  • 10862478000459 ()

  • 5F


  • Supersaturated oxygen therapy system catheter
The TherOx DownStream System, is indicated for the preparation and delivery of SuperSaturated Oxygen Therapy (SSO2 Therapy) to targeted ischemic regions perfused by the patient’s left anterior descending coronary artery immediately following revascularization by means of percutaneous coronary intervention (PCI) with stenting that has been completed within 6 hours after the onset of anterior acute myocardial infarction (AMI) symptoms caused by a left anterior descending artery infarct lesion.
THEROX, INC.
SSO2 - 3.5
In Commercial Distribution

  • 20862478000449 ()
  • 00862478000445 ()
  • 10862478000442 ()

  • 5F


  • Supersaturated oxygen therapy system catheter
The TherOx DownStream System, is indicated for the preparation and delivery of SuperSaturated Oxygen Therapy (SSO2 Therapy) to targeted ischemic regions perfused by the patient’s left anterior descending coronary artery immediately following revascularization by means of percutaneous coronary intervention (PCI) with stenting that has been completed within 6 hours after the onset of anterior acute myocardial infarction (AMI) symptoms caused by a left anterior descending artery infarct lesion.
THEROX, INC.
SSO2 - 4.0
In Commercial Distribution

  • 20862478000432 ()
  • 00862478000438 ()
  • 10862478000435 ()

  • 5F


  • Supersaturated oxygen therapy system catheter
The TherOx DownStream System, is indicated for the preparation and delivery of SuperSaturated Oxygen Therapy (SSO2 Therapy) to targeted ischemic regions perfused by the patient’s left anterior descending coronary artery immediately following revascularization by means of percutaneous coronary intervention (PCI) with stenting that has been completed within 6 hours after the onset of anterior acute myocardial infarction (AMI) symptoms caused by a left anterior descending artery infarct lesion.
THEROX, INC.
DSC-2
In Commercial Distribution

  • 10862478000428 ()
  • 00862478000421 ()


  • Supersaturated oxygen therapy system cartridge
< 1 ... 177 178 179 180 181 ... 1000 >